Northwestern Mutual Wealth Management
HBIO icon

Northwestern Mutual Wealth Management’s Harvard Bioscience HBIO Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-190
Closed -$833 – 4111
2025
Q3 		$833 Buy
+190
New +$901 ﹤0.01% 3579
2017
Q3 		– Sell
-99
Closed -$3K – 2196
2017
Q2 		$3K Buy
+99
New +$2.45K ﹤0.01% 1829

Other funds holding HBIO

WCM
Weber Capital Management San Francisco, California $100M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM

Northwestern Mutual Wealth Management's HBIO Position: Q4 2025 in Review

Northwestern Mutual Wealth Management sold out of Harvard Bioscience (HBIO) in Q4 2025, closing a stake of 190 shares — an estimated $833 sold.

Northwestern Mutual Wealth Management first reported a position in HBIO in Q2 2017 and held it in 2 quarters. The position peaked at $3K in Q2 2017. 64 funds tracked by Wall St. Rank hold HBIO as of Q4 2025.

  • Northwestern Mutual Wealth Management reported no remaining Harvard Bioscience position as of Q4 2025 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 190 Harvard Bioscience shares in Q4 2025, an estimated $833.
  • Northwestern Mutual Wealth Management first reported a position in Harvard Bioscience in Q2 2017 and held it in 2 quarters.
  • Northwestern Mutual Wealth Management's Harvard Bioscience position peaked at $3K in Q2 2017.
  • 64 funds tracked by Wall St. Rank held Harvard Bioscience as of Q4 2025.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2025, filed 5 Feb 2026.